Meta-Analysis
doi: 10.1161/01.str.0000018820.99077.46.
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review)
Affiliations
- PMID: 12105377
- DOI: 10.1161/01.str.0000018820.99077.46
Item in Clipboard
Meta-Analysis
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review)
Stroke.
2002 Jul.
No abstract available
Comment in
-
Cochrane corner.Stroke. 2002 Jul;33(7):1739. doi: 10.1161/01.str.0000024260.47409.45. Stroke. 2002. PMID: 12105336 No abstract available.
Similar articles
-
Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.JAMA. 1998 Apr 22-29;279(16):1265-72. JAMA. 1998. PMID: 9565006 Clinical Trial.
-
Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.Thromb Haemost. 1998 Sep;80(3):530. Thromb Haemost. 1998. PMID: 9759647 No abstract available.
-
A comparative review of the adverse effect profiles of heparins and heparinoids.Drug Saf. 1995 Jan;12(1):26-31. doi: 10.2165/00002018-199512010-00002. Drug Saf. 1995. PMID: 7537967 Review.
-
Ardeparin and danaparoid for prevention of deep vein thrombosis.Med Lett Drugs Ther. 1997 Oct 10;39(1011):94-5. Med Lett Drugs Ther. 1997. PMID: 9379998 No abstract available.
-
Danaparoid: a review of its use in thromboembolic and coagulation disorders.Drugs. 2002;62(15):2283-314. doi: 10.2165/00003495-200262150-00016. Drugs. 2002. PMID: 12381232 Review.
Cited by
-
New treatments in acute ischemic stroke.Curr Treat Options Neurol. 2005 Nov;7(6):499-511. doi: 10.1007/s11940-005-0050-y. Curr Treat Options Neurol. 2005. PMID: 16221373
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
